IP Library Granted Patent US 9,783,560
Granted Patent B2
US 9,783,560 · App. 14/702,499 · Granted Oct 10, 2017

Reagents useful for synthesizing rhodamine-labeled oligonucleotides

Inventors: Scott C. Benson (Alameda, CA); Ruiming N. Zou (Foster City, CA); Krishna G. Upadhya (Union City, CA); Paul M. Kenney (Sunnyvale, CA); Jonathan M. Cassel (Half Moon Bay, CA)
Assignee: Applied Biosystems, LLC
C07F9/6561C07D311/96C07H19/04C07H21/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,783,560
App. No.
14/702,499
Granted
Oct 10, 2017
Kind
B2
Abstract

The present disclosure provides reagents that can be used to label synthetic oligonucleotides with rhodamine dyes or dye networks that contain rhodamine dyes.

Claims (50)

1. A reagent useful for labeling an oligonucleotide, which is a compound according to structural formula (VII):

LM-L-PEP  (VII)

wherein LM represents a label moiety that comprises an N-protected NH-rhodamine moiety, PEP represents a phosphate ester precursor group which comprises a phosphoramidite group or an H-phosphonate group, and L represents an optional linker linking the label moiety to the phosphate ester precursor group, and

further wherein the in which the N-protected NH-rhodamine moiety comprises a structure selected from structural formulae (IIIc), (IIIb) and (IIIc):

wherein:

R′ is selected from R 3′ and hydrogen;

R″ is selected from R 6′ and hydrogen;

R 9 is a protecting group having a structure of the formula —C(O)R 10 , wherein R 10 is selected from hydrogen, a lower alkyl, —CX 3 , —CHX 2 , —CH 2 X, —CH 2 —OR d , and phenyl optionally monosubstituted with a lower alkyl, —X, —OR d , cyano or nitro group, wherein R d is selected from a lower alkyl, phenyl and pyridyl, and each X is a halo group;

each of R 1′ , R 2′ , R 2″ , R 4′ , R 4″ , R 5′ , R 5″ , R 7′ , R 7″ , R 8′ , R 4 , R 5 , R 6 , and R 7 , when taken alone, are each, independently of one another, selected from hydrogen, lower alkyl, (C6-C14) aryl, (C7-C20) arylalkyl, 5-14 membered heteroaryl, 6-20 membered heteroarylalkyl, —R b and —(CH 2 ) x —R b , where x is an integer ranging from 1 to 10 and R b is selected from —X, —OH, —OR a , —SH, —SR a , —NH 2 , —NHR a , —NR c R c , —N + R c R c R c , perhalo lower alkyl, trihalomethyl, trifluoromethyl, —B(OH) 3 , —B(OR a ) 3 , —B(OH)O − , —B(OR a ) 2 O − , —B(OH)(O − ) 2 , —B(OR a )(O − ) 2 , —P(OH) 2 , —P(OH)O − , —P(OR a ) 2 , —P(OR a )O − , —P(O)(OH) 2 , —P(O)(OH)O − , —P(O)(O − ) 2 , —P(O)(OR a ) 2 , —P(O)(OR a )O − , —P(O)(OH)(OR a ), —OP(OH) 2 , —OP(OH)O − , —OP(OR a ) 2 , —OP(OR a )O − , —OP(O)(OH) 2 , —OP(O)(OH)O − , —OP(O)(O − ) 2 , —OP(O)(OR a ) 2 , —OP(O)(OR a )O − , —OP(O)(OR a )(OH), —S(O) 2 O − , —S(O) 2 OH, —S(O) 2 R a , —C(O)H, —C(O)R a , —C(S)X, —C(O)O − , —C(O)OH, —C(O)NH 2 , —C(O)NHR a , —C(O)NR c R c , —C(S)NH 2 , —C(O)NHR a , —C(O)NR c R c , —C(NH)NH 2 , —C(NH)NHR a , and —C(NH)NR c R c , where X is halo, each R a is, independently of the others, selected from lower alkyl, (C6-C14) aryl, (C7-C20) arylalkyl, 5-14 membered heteroaryl and 6-20 membered heteroarylalkyl, and each R e is, independently of the others, an R a , or, alternatively, two R c bonded to the same nitrogen atom may be taken together with that nitrogen atom to form a 5- to 8-membered saturated or unsaturated ring that may optionally include one or more of the same or different ring heteroatoms, which are typically selected from O, N and S, or, alternatively, R 1′ and R 2′ or R 7′ and R 8′ are taken together with the carbon atoms to which they are bonded to form an optionally substituted (C6-C14) aryl bridge and/or R 4′ and R 4″ and/or R 5′ and R 5″ are taken together with the carbon atoms to which they are bonded to form a benzo group; and

each of R 3′ and R 6′ , when taken alone, are each, independently of one another, selected from lower alkyl, (C6-C14) aryl, (C7-C20) arylalkyl, 5-14 membered heteroaryl and 6-20 membered heteroarylalkyl, or alternatively, R 3′ and R 2′ or R 4′ and/or R 6′ and R 5′ or R 7′ in the compounds of structural formula (IIIa), R 3′ and R 2′ or R 4′ and/or R 6′ and R 5′ or R 7″ in the compounds of structural formula (III6), or R 3′ and R 2″ or R 4′ and/or R 6′ and R 5′ or R 7″ in the compounds of structural formula (IIIc) are taken together with the atoms to which they are bonded to form a 5- or 6-membered saturated or unsaturated ring which is optionally substituted with one or more of the same or different lower alkyl, benzo or pyrido groups,

with the proviso that at least one of R 2′ , R 4′ , R 5′ , R 7′ , R 5 or R 6 in the compounds structural formula (IIIa), at least one of R 2′ , R 4′ , R 5′ , R 7″ , R 5 or R 6 in the compounds of structural formula (IIIb) and at least one of R 2″ , R 4′ , R 5′ , R 7″ , R 5 or R 6 in the compounds of structural formula (IIIc) comprises a group of the formula —Y—, where Y is chosen from —C(O)—, —S(O) 2 —, —S—, and —NH.

2. The reagent of claim 1 in which L is selected from —Z—(CH 2 ) 3-6 —O − , —Z—(CH 2 ) a —[(Ar) b —(CH 2 ) a ] c —O—, —Z—(CH 2 ) a —[C≡C—(CH 2 ) a ] c —O—, —Z—(CH 2 ) a —[C≡C—(Ar) b ] c —(CH 2 ) a —O—, —Z—(CH 2 ) d —NH—C(O)—[(CH 2 ) a —(Ar)—(CH 2 ) a —C(O)—NH] c —(CH 2 ) d —O—, and —Z—[CH 2 (CH 2 ) e O] f —CH 2 (CH 2 ) e O—, wherein:

each Z represents, independently of the others, a portion of a linkage contributed by a functional group F z ;

each a represents, independently of the others, an integer ranging from 0 to 4;

each b represents, independently of the others, an integer ranging from 1 to 2;

each c represents, independently of the others, an integer ranging from 1 to 5;

each d represents, independently of the others, an integer ranging from 1 to 10;

each e represents, independently of the others, an integer ranging from 1 to 4;

each f represents, independently of the others, an integer ranging from 1 to 10; and

each Ar represents, independently of the others, an optionally substituted monocyclic or polycyclic cycloalkylene, cycloheteroalkynene, arylene or heteroarylene group.

3. The reagent of claim 2 in which each Ar is, independently of the others, a group derived from cyclohexane, piperazine, benzene, napthalene, phenol, furan, pyridine, piperidine, imidazole, pyrrolidine or oxadizole.

4. The reagent of claim 1 which is a compound according to structural formula (VII.1):

wherein B represents a suitably protected nucleobase and L 2 represents a linker linking nucleobase B to label moiety LM.

5. The reagent of claim 4 in which the nucleobase is selected from adenine, 7-deazaguanine, guanine, 7-deazaguanine, cytosine, uracil, thymine, inosine, xanthene and hypoxanthene.

6. The reagent of claim 4 in which B is selected from A iBu , A Pac , C Ac , G iPr-Pac , T and U.

7. The reagent of claim 4 in which L 2 is selected from —C≡C—CH 2 —NH—, —C≡C—C(O)—, —CH═CH—NH—, —CH═CH—C(O)—, —C≡C—CH 2 —NH—C(O)—(CH 2 ) 1-6 —NH—, —CH═CH—C(O)—NH—(CH 2 ) 1-6 —NH—C(O)—, —C≡CH—CH 2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, —C≡C—C≡C—CH 2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, —C≡C—(Ar) 1-2 —C≡C—CH 2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, —C≡C—(Ar) 1-2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH— and —C≡C—(Ar) 1-2 —O—CH 2 CH 2 —[O—CH 2 CH 2 ] 0-6 —NH—, where Ar is as defined in claim 2 .

8. The reagent of claim 4 in which —B-L 2 - is selected from

9. The reagent of claim 1 further comprising a suitably protected synthesis handle.

10. The reagent of claim 9 which is a compound according to structural formula (VIII):

R e O-L-LM-L-PEP  (VIII)

wherein R e represents an acid-labile protecting group, each L represents, independently of the other, an optional linker, LM represents the label moiety and PEP represents the phosphate ester precursor group.

11. The reagent of claim 9 which is a compound according to structural formula (IX):

wherein LM represents the label moiety, L represents a linker, R e represents an acid-labile protecting group and PEP represents the phosphate ester precursor group.

12. The reagent of claim 1 in which the phosphate ester precursor group comprises a phosphoramidite of the formula (P.1):

wherein:

R 20 is selected from a linear, branched or cyclic saturated or unsaturated alkyl containing from 1 to 10 carbon atoms, 2-cyanoethyl, an aryl containing from 6 to 10 ring carbon atoms and an arylalkyl containing from 6 to 10 ring carbon atoms and from 1 to 10 alkylene carbon atoms; and

R 21 and R 22 are each, independently of one another, selected from a linear, branched or cyclic, saturated or unsaturated alkyl containing from 1 to 10 carbon atoms, an aryl containing from 6 to 10 ring carbon atoms and an arylalkyl containing from 6 to 10 ring carbon atoms and from 1 to 10 alkylene carbon atoms, or, alternatively, R 21 and R 22 are taken together with the nitrogen atom to which they are bonded to form a saturated or unsaturated ring that contains from 5 to 6 ring atoms, one or two of which, in addition to the illustrated nitrogen atom, can be heteroatom selected from O, N and S.

13. The reagent of claim 12 in which R 20 is beta-cyanoethyl and R 21 and R 22 are each isopropyl.

14. The reagent of claim 9 in which the suitably protected synthesis handle comprises 4′,4″-dimethoxytrityl.

15. The reagent of claim 1 in which the N-protected NH-rhodamine moiety comprises a structure selected from structural formulae (IIIa.1), (IIIa.2), (IIIb 0.1), (IIIb 0.2), (IIIc.1) and (IIIc.2):

wherein R′, R″, R 2′ , R 2″ , R 3′ , R 4′ , R 4″ , R 5′ , R 5″ , R 6′ , R 7′ , R 7″ , R 8′ , R 4 , R 5 , R 6 , R 7 , R 9 and Y are as previously defined in claim 1 .

16. The reagent of claim 15 in which the N-protected NH-rhodamine moiety has one or more applicable features selected from:

(i) Y is selected from —C(O)—, —S(O) 2 —, —S— and —NH—;

(ii) R 4 and R 7 are each chloro;

(iii) R 1′ and R 8′ are each hydrogen;

(iv) R 1′ and R 2′ or R 7′ and R 8′ are taken together to form a benzo group;

(v) R 2′ and R 7′ are each hydrogen or lower alkyl;

(vi) R′ is R 3′ and R″ is R 6′ ; and

(vii) R′ is R 3′ , R″ is R 6′ , and R 3′ and R 6′ are taken together with a substituent group on an adjacent carbon atom to form a group selected

from —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —C(CH 3 ) 2 CH═C(CH 3 )—, —C(CH 3 ) 2 CH═CH—, —CH 2 —C(CH 3 ) 2 — and

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2017
From: BENSON, SCOTT C.; ZOU, RUIMING N.; UPADHYA, KRISHNA G.; KENNEY, PAUL M.; CASSEL, JONATHAN M.
To: APPLERA CORPORATION
Reel/Frame 042600/0371 →
CHANGE OF NAME Recorded Jun 5, 2017
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 042600/0381 →
MERGER Recorded Jun 5, 2017
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 042600/0387 →
Continuity (3)
Division 11695548 · Apr 2, 2007
Provisional Application 60787777 · Mar 31, 2006
Related Publication 20150232494A1 · Aug 20, 2015